Why the study?
Do groupings of insulin resistance-related cardiovascular risk factors synergistically increase carotid intimal-medial thickness in adults without diabetes, treated dyslipidemia, or coronary heart disease?
Do groupings of insulin resistance-related cardiovascular risk factors synergistically increase carotid intimal-medial thickness in adults without diabetes, treated dyslipidemia, or coronary heart disease?
The synergistic effect of multiple insulin resistance syndrome components on carotid IMT suggests that treating the syndrome as a whole may reduce atherosclerotic risk more than treating individual factors.
Answers are grounded in this paper and cite their sources.
IRS clustering tied to excess IMT; hypothesis-generating for synergistic effects and should not yet change practice.
The extent to which groupings of insulin resistance-related cardiovascular risk factors synergize to produce atherosclerosis beyond what is expected from their additive effects is uncertain. The objective of this study was to measure interactions among groupings of the features of the insulin resistance syndrome (IRS) on carotid intimal-medial thickness (IMT). This cross-sectional study used baseline data from the Atherosclerosis Risk in Communities Study on 11,790 adults aged 45-64 years without diagnosed diabetes, treated dyslipidemia, or coronary heart disease. The main outcome was carotid IMT, assessed using B-mode ultrasound. The excess carotid IMT attributable to each IRS grouping was determined using multiple linear regression models. There were 57 possible combinations of six IRS components (hypertension, hyperinsulinemia, obesity, hypertriglyceridemia, low HDL cholesterol, and hyperglycemia). In multivariate analysis, 29 of the 57 groupings were associated with excess carotid IMT. Individuals with all six IRS components had the greatest excess IMT compared with those without this grouping (71 micro m; 95% CI 40-102 micro m). The groupings most strongly associated with excess carotid IMT included hypertension and hypertriglyceridemia. Interventions aimed at ameliorating the IRS may produce reductions in atherosclerotic risk beyond that predicted by treatment of individual IRS-related risk factors.
No takes yet. Share an insight, caveat, or question.
Golden et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: